Mangus L.M. et. al., SIV-Induced Immune Activation and Metabolic Alterations in the Dorsal Root Ganglia During Acute Infection., 10.1093/jnen/nly111., J Neuropathol Exp Neurol. , Jan 01, 2019 ➔

Butto L.F. et. al., Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Experimental Crohn's Disease., 10.1093/ibd/izy305., Inflamm. Bowel Dis., Jan 01, 2019 ➔

Ryall S. et. al., Detecting Stem Cell Marker Expression Using the NanoString nCounter System., 10.1007/978-1-4939-8805-1_5., Methods Mol. Biol., Jan 01, 2019 ➔

Augier E. et. al., A molecular mechanism for choosing alcohol over an alternative reward, 10.1126/science.aao1157, Science, Dec 19, 2018 ➔

Lopez-Knowles E. et. al., Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations, 10.1038/s41416-018-0345-x, Br. J. Can, Dec 19, 2018 ➔

Hisamatsu T. et. al., PRKRA/PACT Expression Promotes Chemoresistance of Mucinous Ovarian Cancer, 10.1158/1535-7163.MCT-17-1050, Mol. Can. Ther., Dec 18, 2018 ➔

Sharma P. et. al., Transcriptomics reveals complex kinetics of dorsal‐ventral patterning gene expression in the mandibular arch, 10.1002/dvg.23275, Genesis, Dec 18, 2018 ➔

Watts A.M. et. al., Distinct Gene Expression Patterns between Nasal Mucosal Cells and Blood Collected from Allergic Rhinitis Sufferers., 10.1159/000489609, Int Arch Allergy Immunol. , Dec 18, 2018 ➔

El Jamal S.M. et. al., MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like type, https://doi.org/10.1038/s41374-018-0152-2, Lab Invest., Dec 17, 2018 ➔

Cui T. et. al., miR-4516 predicts poor prognosis and functions as a novel oncogene via targeting PTPN14 in human glioblastoma, https://doi.org/10.1038/s41388-018-0601-9, Oncogene, Dec 17, 2018 ➔

Neubauer C. et. al., Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum., 10.1128/JB.00365-18, J. Bacteriol., Dec 15, 2018 ➔

Bommareddy P.K. et. al., MEK inhibition enhances oncolytic virus immunotherapy through increased tumor cell killing and T cell activation, 10.1126/scitranslmed.aau0417 , Science, Dec 12, 2018 ➔

Aronchik I. et. al., Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance, 10.1158/1541-7786.MCR-17-0554, Mol. Can. Res., Dec 12, 2018 ➔

Chon H.J. et. al., Tumor microenvironment remodeling by intratumoral oncolytic vaccinia virus enhances the efficacy of immune checkpoint blockade., 10.1158/1078-0432.CCR-18-1932, Clin. Can. Res., Dec 11, 2018 ➔

Chang J.C. et. al., Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK gene rearrangements., 10.1016/j.jtho.2018.12.003, J. Thorac Oncol., Dec 11, 2018 ➔